Menopause and perimenopause: symptoms and hormone therapy
Perimenopause is the years-long transition when estrogen fluctuates and periods become irregular; menopause is the point 12 months after your last period. Common symptoms include hot flashes, sleep disruption, mood changes, and vaginal or urinary changes. Hormone therapy replaces declining estrogen and, for many symptomatic women, is an appropriate, individualized option a licensed provider decides.
The perimenopause-to-menopause timeline
Perimenopause is the transition leading up to menopause. It often begins in a woman's 40s (sometimes earlier) and can last several years. During this time the ovaries produce estrogen and progesterone less predictably, so hormone levels swing rather than simply decline — which is why symptoms can come and go.
Menopause itself is a single point in time: it is defined as 12 consecutive months without a menstrual period, occurring on average around age 51. The years afterward are called postmenopause. Because estrogen stays low after menopause, some symptoms — especially vaginal and urinary changes — can persist or first appear during this phase.
Common symptoms
Symptoms vary widely from woman to woman in type, timing, and severity. Some women have few; others find symptoms disrupt sleep, work, and relationships. They are driven largely by fluctuating and then falling estrogen.
- Hot flashes and night sweats (vasomotor symptoms) — the most recognized symptom, ranging from mild warmth to drenching sweats.
- Sleep disruption — trouble falling or staying asleep, sometimes worsened by night sweats.
- Mood changes — irritability, anxiety, low mood, or difficulty concentrating (brain fog).
- Vaginal and urinary changes — dryness, discomfort with intercourse, and more frequent urinary tract infections (the genitourinary syndrome of menopause).
- Irregular periods during perimenopause — cycles that lengthen, shorten, or become heavier or lighter before stopping.
What hormone therapy does
Menopausal hormone therapy (HRT) replaces some of the estrogen the ovaries no longer make. It is the most effective treatment for hot flashes and night sweats, and it also treats vaginal dryness and other genitourinary symptoms. Systemic estrogen can be delivered as a pill, a skin patch, a gel, or a spray.
Estrogen alone stimulates the lining of the uterus (the endometrium). In a woman who still has her uterus, unopposed estrogen raises the risk of endometrial overgrowth and cancer, so estrogen must be paired with a progestogen for endometrial protection. Women who have had a hysterectomy can generally use estrogen alone.
The modern, individualized benefit/risk view (post-WHI)
Early headlines from the Women's Health Initiative (WHI) in the early 2000s led many women and clinicians to abandon hormone therapy. Later re-analyses added crucial nuance: the balance of benefits and risks depends heavily on a woman's age and how many years she is from menopause when she starts.
For most healthy women under 60, or within 10 years of menopause, who have bothersome symptoms, major medical societies now consider hormone therapy an appropriate option because benefits generally outweigh risks in that window. Risks — which can include blood clots, stroke, and, with certain regimens, a small increase in breast cancer risk over time — rise with older age and later initiation. There is no one-size-fits-all answer: a licensed provider weighs your symptoms, personal and family history, and preferences to individualize the decision, the formulation, and the dose.
Bioidentical estradiol and progesterone for endometrial protection
Bioidentical hormones are chemically identical to those the body makes. Estradiol (the main estrogen) and micronized progesterone are FDA-approved bioidentical hormones that a provider can prescribe — distinct from custom compounded bioidentical blends, which are not FDA-approved and are not tested for consistency.
If you take systemic estradiol and still have your uterus, you need a progestogen for endometrial protection. Standard, evidence-based options are oral micronized progesterone or a progestin. Do not rely on a topical or transdermal progesterone product to protect the endometrium against systemic estrogen. Your provider selects the specific regimen; this page does not replace that clinical decision.
What is the difference between perimenopause and menopause?
Perimenopause is the transition of several years when hormones fluctuate and periods become irregular. Menopause is the single point 12 months after your last period. The years after are postmenopause.
Is hormone therapy safe?
For most healthy women under 60 or within 10 years of menopause who have bothersome symptoms, major societies consider it an appropriate option where benefits generally outweigh risks. Risks rise with older age and later start. It is an individualized, provider-supervised decision.
Do I need progesterone if I take estrogen?
If you still have your uterus and take systemic estrogen, yes — a progestogen protects the endometrium against overgrowth and cancer. Standard options are oral micronized progesterone or a progestin. Women who have had a hysterectomy generally use estrogen alone.
Are bioidentical hormones better than other hormones?
FDA-approved bioidentical estradiol and micronized progesterone are well-studied and widely used. Custom compounded bioidentical blends are not FDA-approved, not tested for consistency, and not proven safer. A provider helps you choose an evidence-based regimen.
How do I start with Medivive?
Start a conversation — no quiz, no forms. This page is educational and not medical advice; a licensed provider determines whether any treatment is appropriate for you and, if so, which regimen and dose.